Hearing on "An Examination of How Reining in PBMs Will Drive Competition and Lower Costs for Patients"
The Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Wednesday, February 26, 2025, at 10 a.m. (EST) in the John D. Dingell Room, 2123 Rayburn House Office Building. The hearing is entitled "An Examination of How Reining in PBMs Will Drive Competition and Lower Costs for Patients."
Key Documents
Opening Statement from Full Committee Ranking Member Pallone as prepared for delivery
Opening Statement from Subcommittee on Health Ranking Member DeGette as prepared for delivery
Livestream
Witnesses
Mr. Hugh Chancy, RPh
Pharmacist and Owner
Chancy Drugs
Dr. Matthew Fiedler, PhD
Joseph A. Pechman Senior Fellow
Center on Health Policy, Brookings Institution
Mr. Shawn Gremminger, MPH
President and CEO
National Alliance of Healthcare Purchaser Coalitions
Mr. Anthony Wright
Executive Director
Families USA